日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis

那他珠单抗 6 周给药与持续 4 周给药治疗复发缓解型多发性硬化症的药代动力学和药效学

John F Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A Cohen, Douglas L Arnold, Helmut Butzkueven, Gary R Cutter, Gavin Giovannoni, Joep Killestein, Heinz Wiendl, Kexuan Li, Liesel Dsilva, Marie Toukam, Kyle Ferber, Jihee Sohn, Holly Engelman, Tyler Lasky

Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis

接受高剂量生物素治疗的进行性多发性硬化症患者的复发

Mathais, Sophie; Moisset, Xavier; Pereira, Bruno; Taithe, Frédéric; Ciron, Jonathan; Labauge, Pierre; Dulau, Cécile; Laplaud, David; De Seze, Jérôme; Pelletier, Jean; Berger, Eric; Lebrun-Frenay, Christine; Castelnovo, Giovanni; Edan, Gilles; Defer, Gilles; Vermersch, Patrick; Bourre, Bertrand; Camdessanche, Jean-Philippe; Magy, Laurent; Guennoc, Anne-Marie; Mathey, Guillaume; Moreau, Thibault; Gout, Olivier; Heinzlef, Olivier; Maillart, Elisabeth; Vukusic, Sandra; Clavelou, Pierre

Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin

通过 P-选择素分子磁共振成像预测多发性硬化症模型中的疾病活动性

Antoine Philippe Fournier, Aurélien Quenault, Sara Martinez de Lizarrondo, Maxime Gauberti, Gilles Defer, Denis Vivien, Fabian Docagne, Richard Macrez